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Abstract 
     Gene transduction and expression efficiencies among several type cell lines were compared 
by using vesicular stomatitis virus-glycoprotein (VSV-G) pseudotyped human immunodeficiency 
virus type-1 (HIV-1) based lentivirus vector. Large discrepancies of the efficiencies were shown 
among them. B lymphocytes showed high susceptibility of the gene transduction and expression, 
while other cell lines marked lower potential. Variable gene transduction strategies have been 
assessed to apply immunological therapies. This study showed that B lymphocytes had facilities 
enough to support the gene transduction and expression by lentivirus vector. Our result suggested 
that the lentivirus vector would be a powerful tool to express exogenous genes in B lymphocytes. 
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Introduction 
     Lentivirus based vector has much potential for being applied to a gene delivery vehicle. 
Different from other types of vectors, lentivirus vector can deliver exogenous genes into not only 
dividing cells but also non-dividing cells (1). The expression from the delivered genes can be 
further maintained stably with little gene silencing. Since exogenous genes are integrated into the 
host genome, proliferating cells can keep those genes permanently. The expression of the 
exogenous genes introduced by lentivirus vector needs several cellular factors, those support 
transcription of messenger RNA from long terminal repeat (LTR) region on provirus DNA. The 
capacity of supporting the expression of exogenous genes is various among cell types. It is 
important to clear why some cells have high susceptibility to lentivirus infection while others mark 
less potential, in order to characterize the biological interaction of lentivirus and target cell. That 
would become the essential knowledge to obtain desirable outcome in gene therapy using lentivirus 
vector. The comparisons of gene transduction and expression efficiencies among several types of 
cell lines have been hardly focused. This study demonstrates that several B lymphocytes-originated 
cells have high susceptibility to the gene transduction and expression by lentivirus vector while 
other types of cells have low capacity. Lentivirus vector would be applicable to treat B lymphocyte 
associated disorders. 
 
Materials and Methods 
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Cells and Pseudotyped Virus: MT-4, MOLT-4#8, Jurkat#E6-1, HUT78, H9, PM-1, CEM, 
CEMx174#T-1, Ramos, BJA-B, Daudi, P3HR-1#G, Namalwa, BCBL-1, U937 and K562 cells 
were maintained in RPMI-1640 medium (ICN, Costa Mesa, CA) supplied with 10% of heat 
inactivated fetal calf serum (PAA, Linz, Austria), 100 mg/ml of streptomycin (Meiji, Tokyo, 
Japan) and 100 IU/ml of penicillin (Banyu, Tokyo, Japan). Luciferase reporter gene carrying 
pseudotyped virus was made by transfection of pNL4-3-luc plasmid DNA (2) with vesicular 
stomatitis virus glycoprotein (VSV-G) expression vector into 293T cell by calcium phosphate 
precipitation method. Three days after transfection, pseudotyped virus containing supernatant was 
harvested and passed through 0.45 μ m filter (Millipore). 
Luciferase Assay: VSV-G pseudotyped virus (2 ng) infected 1 x 106 cells. One hour later, cell-free 
virus was removed. Then, cell was cultured in 24-wells plate in 1 ml medium. Seventy-two hours 
post virus infection, cell was washed with magnesium and calcium ions free phosphate buffered 
saline twice and lysed with 100 μ l of 1 x lysis buffer (Promega, Madison, WI). Luciferase activity 
was measured after mixing 10 μ l of lysate with 50 μ l of luciferase substrate solution (Promega) 
by counting the light intensity with luminometer (Lumat LB 9501/16; EG&G Berthold, Bad 
Wildbad, Germany). 
Polymerase chain reaction (PCR): Twenty-four hours post psuedotyped virus inoculation on 1 x 
106 cells, the amount of provirus DNA was quantified by PCR. Briefly, cell was lysed with urea 
lysis buffer (4.7 M urea, 1.3% SDS, 0.23 M NaCl, 0.67 mM EDTA, 6.7 mM Tris pH 8.0). DNA 
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was isolated by phenol chloroform extraction method followed by ethanol precipitation. PCR was 
performed in 1 x PCR buffer (20 mM Tris pH 8.0, 50 mM KCl, 1.5 mM MgCl2, 0.2 mM each 
dNTPs and 0.05 U/l recombinant Taq DNA polymerase) with each 0.5 mM of M667 
(5’-GGCTAACTAGGGAACCCACTG-3’) and M661 
(5’-CCTGCGTCGAGAGAGCTCTGGTTT-3’) primers to amplify provirus DNA (R/gag region), 
or glo-A (5’-ACACAACTGTGTTCACTAGC-3’) and glo-B 
(5’-CAACTTCATCCACGTTCACC-3’) primers to amplify - globin coding DNA (3). PCR 
reaction was programmed as first denature for 5 min at 94˚C, followed with 30 cycles of reaction as 
denature for 1 min at 94˚C, as annealing for 1 min at 65˚C (R/gag) or at 55˚C (- globin), as 
extension for 2 min at 72˚C, and finally extension for 10 min at 72˚C. All PCR was done by Takara 
Thermal Cycler MP (Takara, Kyoto, Japan). 
 
Results and discussion 
     Gene transduction and expression efficiencies among several types of cell lines mediating by 
VSV-G pseudotyped HIV-1 based lentivirus vector were compared. MT-4 cell, which was 
transformed by human T cell leukemia/lymphoma virus type-I (HTLV-I), and all tested B 
lymphocytes showed high susceptibility to the gene transduction by lentivirus vector. In contrast, T 
lymphocytes except MT-4 and other types (monocyte and myeloma) of cells showed low 
susceptibility (Fig. 1A). One logarithmic scale or more gaps of luciferase activity counts were 
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observed among B lymphocytes and other types of cells. CEMx174 cell (complex of T and B 
lymphocytes) showed middle level of susceptibility to lentivirus vector mediated gene transduction 
and expression. 
     Provirus DNA formation capacities were compared among all tested cell lines by PCR 
method. There were no remarkable discrepancies of provirus DNA formation among all tested 
cells (Fig. 1B). These results indicated that the potential of integrated gene expression varied among 
cell types. Especially, B lymphocytes had higher capacity to help provirus DNA transcription than 
other type cells. Relative gene expression amounts calibrated by cellular DNA amounts were 
aligned in Figure 1C. It cleared the large varieties of gene expression levels were due to some 
cellular factors. Herpes virus negative B lymphocytes (Ramos and BJA-B) showed high 
susceptibility to lentivirus vector mediating gene transduction and expression. It suggested that high 
expression level of reporter gene was not due to any factors, which derived from herpes viruses 
(Epstein-Barr virus; Daudi, P3HR-1 and Namalwa, or Kaposi sarcoma associated herpes virus; 
BCBL-1). 
     All used T lymphocytes released some factors into culture supernatant. Those enhanced the 
infection of HIV-1 to cells. In contrast, B lymphocytes except BJA-B did not produce any factors 
(4). However, no remarkable discrepancies about the quantities of synthesized provirus DNA were 
observed among each type of cells (Fig. 1B). It suggested that the virus entry and provirus DNA 
synthesis occurred equally in all tested cells. This result denied that soluble factors in culture 
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supernatant enhanced the virus entry and provirus DNA formation efficiencies. These 
discrepancies might be derived from the difference of target cells characters. Because this study 
used flowing cells since previous study (4) used adherent cells to calculate the virus infection 
efficiency. Previous study showed culture supernatant of T lymphocytes contained some cellular 
factors, which accelerated the progression of HIV-1 infection to CD-4 positive Hela cell. 
Undetermined factors were presumed to prompt virus entry. Different from the previous report, this 
study was performed with lymphocytes as virus target cells instead of Hela cell. These differences 
of study designs might bring the opposite results. Some modulation of virus replication efficiency 
at post integration steps might bring the gap of the gene transduction and expression efficiencies 
among each cell. Many research showed that the expression of provirus DNA was influenced by 
various factors. DNA methylation, change of chromatin structure and association of histone protein 
induced gene silencing (5-8). Several cellular proteins regulated provirus DNA silencing (9-14). 
Many molecules were identified as transcriptional modulators. These cellular machineries 
influenced the amounts of messenger RNA transcription from provirus LTR. In addition, 
integration of provirus into host genome occurred to restricted local hotspot dominantly (15). 
Further, the transcription activity was controlled by integration site dependent manner (16). 
Provirus, inserted in lamin-associated domains (LADs), had lower activity of LTR transcription. 
These evidences were obtained by studies used by single type of cell, respectively. However, the 
comparisons of the gene silencing intensity among different types of cell were little in our 
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knowledge. It is unclear whether provirus prefers to integrate in LADs in T lymphocytes or B 
lymphocytes carry much more transcription supporting factors than T lymphocytes. Results of our 
study would open the new research field to clear the cell type dependent regulation of exogenous 
genes transduced by lentivirus vector. 
     Several cellular transcription factors prompted gene transcription from LTR (17-21). 
Previous reports and Figure 1A suggested that differences of transcription factors’ expression 
pattern among cells made a large gap of susceptibilities to lentivirus vector mediating gene 
transduction and expression. B lymphocytes might carry enough amounts of factors which support 
transcription from LTR than other type cells did. In contrast, high susceptibility of MT-4 cell to 
lentivirus vector mediating gene transduction and expression were due to the enhancement of 
transcription level by HTLV-I derived Tax protein (22). 
     Clinical application of lentivirus vector to a vehicle of exogenous gene has fronted some 
difficulties that should be conquered. The concentration of vector virus and the length of vector 
virus exposure time are critical to get enough outcomes (23). Gene transduction and expression 
efficiencies depend on the concentration and the exposure time of vector virus. However, virion 
would be inactive within one-day incubation at 37C. It makes the limitation of gene transduction 
and expression efficiencies. Genetic modifications of lentivirus vector are essential to sophisticate 
gene transduction strategy (24-27). Expression level of the exogenous genes from integrated 
provirus has an important role to success gene therapies. Gene transduction into B lymphocytes by 
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several available methods has still some difficulties in clinical application, including low efficiency 
of gene transfer into cells. To conquer the difficulty, several groups have presented some strategies 
(1, 28, 29). This study showed that HIV-1 based lentivirus vector possessed the potential enough to 
introduce exogenous genes into B lymphocytes. Furthermore, lentivirus vector could maintain high 
expression level from the delivered genes in B lymphocytes (Fig. 1A). We demonstrate that 
lentivirus based vector would be a powerful tool for exogenous genes delivery into lymphocytes. 
Using lentivirus vector would be applicable to many fields that need high gene transduction and 
expression efficiencies. 
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Figure legends 
Figure 1 
(A) Comparison of gene transduction and expression efficiencies by VSV-G enveloped lentivirus 
vector. T lymphocytes (MT-4, MOLT-4#8, Jurkat#E6-1, HUT-78, H9, PM-1, CEM), T and B 
complex cell (CEMx174#T-1), B lymphocytes (Ramos, BJA-B, Daudi, P3HR-1#G, Namalwa, 
BCBL-1), monocyte cell (U937) and myeloid cell (K562) were used as target cells. Infectivity 
was measured at three days post infection by luciferase assay. Vertical axis meant the light 
counts of luciferase activities. Representative result of three times experiments, which were 
performed with using different times cultured cells, was aligned. Average counts were showed 
by black bars. All experiments were performed as triplicate assay (n=3). Every result of 
absolute count in same type of cell was within 1% discrepancy.  
 
(B)  Quantification of synthesized provirus DNA amount by PCR. Two-ng of vector virus 
infected 1 x 106 cells. One day after infection, total DNA was extracted and subjected to the 
PCR analysis. PCR products were separated by electrophoresis in 2% agarose gel. The 
quantities of PCR products were measured by densidometer. Vertical axis meant the light 
intensity of provirus DNA product band calibrated by ß-globin DNA amount (light intensity of 
provirus DNA/ß-globin DNA). Representative result of two times experiments, which were 
performed with using different times cultured cells, was aligned. Every experiment was done as 
single assay (n=1). 
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 (C)  Relative gene expression levels were compared. Vertical axis meant the gene expression 
amount, which was calibrated by the provirus DNA amount. The equation of calibration was 
that; light count of luciferase activities/protein amount/ light intensity of provirus DNA/ light 
intensity of -globin DNA. Representative result of two times experiments, which were 
performed with using different times cultured cells, was aligned. Every experiment was done as 
single assay (n=1). Every calibration results showed similar tendency. 
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 Figure 1 
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